Top Section/Bond comments/Ad
Top Section/Bond comments/Ad
Most recent
EFSF and Land NRW are expected to price new trades on Tuesday
Inaugural European Green Bond Standard deal in the works as issuer remains committed to at least one green bond each year with or without new label
World Bank-managed issuer taps capital markets to accelerate donor pledges into Gavi vaccine programmes
◆ Issuer plans regular appearance after 'warm welcome' ◆ Two euro bonds yet to come ◆ Inaugural covered deal not expected until late 2027
More articles/Ad
More articles/Ad
More articles
-
Investors turned out in force as KfW brought its first benchmark green bond of the year this week. The strong demand allowed the German agency to print its joint biggest ever green bond on the back of its largest ever order book for such a deal along with an attractive pricing advantage over a conventional bond. -
The Swiss franc market is having a busy year, with a strong showing from corporate and SSA issuers helping the market to its highest year to date volume since 2015, according to Dealogic.
-
Euro investors are sniffing around further out along the SSA curve, with Euratom returning after a two year absence to print a 10 year bond earmarked to fund power plant safety measures in Ukraine, while the Treasury Corp of Victoria tapped demand past the 30 year point.
-
Swedish Export Credit Corporation kept the public sector new issues market open on Thursday as it came with an opportunistic four year dollar trade on the back of a strong week for dollar borrowers.
-
The European Stability Mechanism is likely to use its funding window scheduled for next week to issue a dollar benchmark, according to SSA bankers.
-
The International Finance Facility for Immunisation (IFFIm) was set up in 2006 to provide funding to Gavi, the Vaccine Alliance, itself a public/private sector partnership, to expedite the vaccination of children in the poorest countries against endemic infectious diseases. Doris Herrera-Pol, IFFIm board member and former director of global capital markets at the World Bank, spoke to GlobalCapital about the role the capital markets can play in the development and deployment of a Covid-19 vaccine.
